Bioanalytical Services
 |
PharmaNet offers bioanalytical laboratory services through its subsidiaries: Anapharm, Anapharm Europe, Keystone Analytical and Taylor Technology.
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
 |
 |
 |
 |
 |
| Ebastine; Carbastine | Respiratory | LC/MS/MS | 50-20000 pg/mL ; 1-400 ng/mL | Human EDTA K3 Plasma |
| Efavirenz | Infectious Disease | LC/MS/MS | 20-4000 ng/mL | Human Plasma |
| Eletriptan; Desmethyl eletriptan | Pain | LC/MS/MS | 500-250000 pg/mL | Human EDTA Plasma |
| Enalapril; Enalaprilat | Cardiovascular | LC/MS/MS | 0.5-100 ng/mL | Human EDTA Plasma |
| Enalapril; Enalaprilat | Cardiovascular | LC/MS/MS | 0.5-200 ng/mL | Human EDTA Plasma |
| Eniluracil | Oncology | LC/MS/MS | 1-250 ng/mL | Human Plasma |
| Entacapone | Central Nervous System Agents | LC/MS/MS | 10-2000 ng/mL | Human EDTA Plasma |
| Ephedrine | Respiratory | LC/MS/MS | 1-100 ng/ml | Human EDTA Plasma |
| Epirubicin | Oncology | LC/MS/MS | 5-1000 ng/mL | Rabbit Plasma |
| Epirubicin;Epirubicinol | Oncology | LC/MS/MS | 5-1000 ng/mL; 2-200 ng/mL | Human Sodium Heparinized Plasma |
| Eplerenone | Cardiovascular | LC/MS/MS | 10-2500 ng/mL | Human EDTA Plasma |
| Erlotinib | Oncology | LC/MS/MS | 10-5000 ng/mL | Human Plasma |
| Erythromycin | Infectious Disease | LC/MS/MS | 20-1000 ng/mL | Human EDTA Plasma |
| Erythromycin | Infectious Disease | LC/MS/MS | 50-20000 ng/mL | Human Urine |
| Erythromycin; Erythromycin Ethylsuccinate | Infectious Disease | LC/MS/MS | 20-2000 ng/mL | Human EDTA Plasma |
| Erythropoietin | Miscellaneous | ELISA | 10-4000 mIU/mL | Human Serum |
| Escitalopram | Central Nervous System Agents | LC/MS/MS | 0.2-50 ng/mL | Human Plasma |
| Escitalopram | Central Nervous System Agents | LC/MS/MS | 0.2-30 ng/mL | Human K3 EDTA Plasma |
| Esomeprazole | Gastrointestinal | LC/MS/MS | 1.5-750 ng/mL | Human EDTA Plasma |
| Estradiol | Endocrinology | LC/MS/MS | 2.5-100 pg/mL | Human EDTA Plasma |
| Estradiol; 17 Beta | Endocrinology | GC/MS/MS | 0.625-80 pg/mL | Human Serum |
| Estradiol; 17 beta | Endocrinology | GC/MS/MS | 0.625-80 pg/mL | Human Heparin Plasma |
| Estrone | Endocrinology | GC/MS/MS | 1.56-200 pg/mL | Human Heparin Plasma |
| Estrone | Endocrinology | GC/MS/MS | 1.56-200 pg/mL | Human Serum |
| Estrone (Total) | Endocrinology | LC/MS/MS | 50-50000 pg/mL | Human EDTA Plasma |
| Estrone Conjugates | Endocrinology | GC/MS/MS | 3.13-800 pg/mL | Human Heparin Plasma |
| Estrone Conjugates | Endocrinology | GC/MS/MS | 3.13-800 pg/mL | Human Serum |
| Estrone; Estradiol | Endocrinology | LC/MS/MS | 5-1000 pg/mL and 2.5-100 pg/mL | Post Menopausal Human EDTA Plasma |
| Eszopiclone | Central Nervous System Agents | LC/MS/MS | 0.25-50 ng/mL | Human Plasma |
| Ethanol | Miscellaneous | GC/MS | 5-500 µg/mL | Human Whole Blood |
| Ethinyl Estradiol | Endocrinology | LC/MS/MS | 1-100 pg/mL | Human EDTA Plasma |
| Ethinyl Estradiol; Nestorone | Endocrinology | GC/MS/MS | 10-1000 pg/mL; 50-5000 pg/mL | Human Serum |
| Ethinyl Estradiol;Gestodene | Endocrinology | LC/MS/MS | 2-250 pg/mL;50-25000 pg/mL | Human EDTA Plasma |
| Etidronic Acid | Rheumatology | GC/MS | 2-800 ng/mL | Human EDTA Plasma |
| Etodolac | Pain | HPLC/UV | 100-40000 ng/mL | Human EDTA Plasma |
| Etonogestrel(3-Ketodesogestrel) | Endocrinology | LC/MS/MS | 25-5000 pg/mL | Human EDTA Plasma |
| Etoposide | Oncology | LC/MS/MS | 20-5000 ng/mL | Human Serum |
| Etoposide | Oncology | LC/MS/MS | 20-5000 ng/mL | Human EDTA Plasma |
| Everolimus | oncology | LC/MS/MS | 100-100000 pg/mL | Human Whole Blood |
| Exemestane | Oncology | LC/MS/MS | 200-40000 pg/mL | Human Sodium Heparinized Plasma |
| Exemestane | Oncology | LC/MS/MS | 200-30000 pg/mL | Human EDTA Plasma |
| Ezetimibe (Total) | Cardiovascular | LC/MS/MS | 200-75000 pg/mL | Human EDTA Plasma |
| Ezetimibe (Unconjugated) | Cardiovascular | LC/MS/MS | 40-10000 pg/mL | Human EDTA Plasma |